You are here

Article Text

Article menu
Download PDFPDF
Treatment
HRT did not reduce coronary events in postmenopausal women with existing heart disease

https://doi.org/10.1136/ebn.2.2.52

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Hulley S, Grady D, Bush T, et al, for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.JAMA1998 Aug 19;280:605–13OpenUrlCrossRefPubMedWeb of Science

    Question Can oestrogen plus progestin prevent recurrent non-fatal myocardial infarction (MI) and coronary heart disease (CHD) mortality in postmenopausal women with established CHD?

    Design

    Randomised, double blind, placebo controlled trial with mean follow up of 4.1 years (Heart and Estrogen/progestin Replacement Study [HERS]).

    Setting

    20 outpatient and community settings in the US.

    Patients

    2763 postmenopausal women between 44 and 79 years of age (mean age 67 y, 89% white) with established CHD who had not had a hysterectomy. Exclusion criteria were CHD event ≤6 months before study; sex hormone use ≤3 months before study; history of breast cancer, deep vein thrombosis, pulmonary embolism, hyperplasia, or endometrial cancer; abnormal mammogram or Papanicolaou test; increased serum triglyceride or serum aspartate aminotransferase concentrations; geographic inaccessibility; …

    View Full Text

    Footnotes

    • Source of funding: Wyeth-Ayerst Research.

    • For correspondence: Dr S Hulley, University of California, San Francisco, Box 0886, San Francisco, CA 94143, USA. Fax +1 415 476 6014.

    • A modified version of this abstract appears in ACP Journal Club.